EE03192B1 - Isopropüül-(2-metoksüetüül)-4-(2-kloro-3-tsüanofenüül)-1,4-dihüdro-2,6-dimetüülpüri diin-3,5-dikarboksülaat, selle enantiomeerid ja vaheühend, meetodid nimetatud ühendite valmistamiseks ja kasutamine - Google Patents

Isopropüül-(2-metoksüetüül)-4-(2-kloro-3-tsüanofenüül)-1,4-dihüdro-2,6-dimetüülpüri diin-3,5-dikarboksülaat, selle enantiomeerid ja vaheühend, meetodid nimetatud ühendite valmistamiseks ja kasutamine

Info

Publication number
EE03192B1
EE03192B1 EE9400393A EE9400393A EE03192B1 EE 03192 B1 EE03192 B1 EE 03192B1 EE 9400393 A EE9400393 A EE 9400393A EE 9400393 A EE9400393 A EE 9400393A EE 03192 B1 EE03192 B1 EE 03192B1
Authority
EE
Estonia
Prior art keywords
preparation
dimethylpyridine
cyanophenyl
methoxyethyl
dihydro
Prior art date
Application number
EE9400393A
Other languages
English (en)
Inventor
Meier Heinrich
Hartwig Wolfgang
Junge Bodo
Schohe-Loop Rudolf
Gao Zhan
Schmidt Bernard
De Jonge Maarten
Schuurman Teunis
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4342194A external-priority patent/DE4342194A1/de
Priority claimed from DE19944424677 external-priority patent/DE4424677A1/de
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of EE03192B1 publication Critical patent/EE03192B1/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
EE9400393A 1993-12-10 1994-11-22 Isopropüül-(2-metoksüetüül)-4-(2-kloro-3-tsüanofenüül)-1,4-dihüdro-2,6-dimetüülpüri diin-3,5-dikarboksülaat, selle enantiomeerid ja vaheühend, meetodid nimetatud ühendite valmistamiseks ja kasutamine EE03192B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4342194A DE4342194A1 (de) 1993-12-10 1993-12-10 Halogen-phenyl-substituierte 1,4-Dihydropyridine
DE19944424677 DE4424677A1 (de) 1994-07-13 1994-07-13 Isopropyl-(2-methoxyethyl)-4-(2-chlor-3-cyano-phenyl)-1,4-dihydro-2,6-dimethyl-pyridin-3,5-dicarboxylat

Publications (1)

Publication Number Publication Date
EE03192B1 true EE03192B1 (et) 1999-06-15

Family

ID=25931956

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9400393A EE03192B1 (et) 1993-12-10 1994-11-22 Isopropüül-(2-metoksüetüül)-4-(2-kloro-3-tsüanofenüül)-1,4-dihüdro-2,6-dimetüülpüri diin-3,5-dikarboksülaat, selle enantiomeerid ja vaheühend, meetodid nimetatud ühendite valmistamiseks ja kasutamine

Country Status (35)

Country Link
US (1) US5665740A (et)
EP (1) EP0657430B1 (et)
JP (1) JP3751041B2 (et)
KR (1) KR100332325B1 (et)
CN (2) CN1056606C (et)
AT (1) ATE180774T1 (et)
AU (1) AU686976B2 (et)
BG (1) BG62487B1 (et)
CA (1) CA2137525C (et)
CO (1) CO4290426A1 (et)
CU (1) CU22713A3 (et)
CZ (1) CZ286065B6 (et)
DE (1) DE59408350D1 (et)
DK (1) DK0657430T3 (et)
DZ (1) DZ1831A1 (et)
EE (1) EE03192B1 (et)
ES (1) ES2132308T3 (et)
FI (1) FI105681B (et)
GR (1) GR3030436T3 (et)
HR (1) HRP940967B1 (et)
HU (1) HU215593B (et)
IL (1) IL111922A (et)
LV (1) LV11321B (et)
MA (1) MA23392A1 (et)
MY (1) MY111976A (et)
NO (1) NO302362B1 (et)
NZ (1) NZ270087A (et)
PL (1) PL179973B1 (et)
RO (1) RO115800B1 (et)
SA (1) SA95160078B1 (et)
SK (1) SK282399B6 (et)
SV (1) SV1994000072A (et)
TN (1) TNSN94127A1 (et)
TW (1) TW412529B (et)
YU (1) YU48920B (et)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1952824A1 (en) * 2003-11-21 2008-08-06 Memory Pharmaceuticals Corporation Compositions and methods of treatment using L-type calcium channel blockers and cholinesterase inhibitors
WO2008058234A2 (en) * 2006-11-08 2008-05-15 Memory Pharmaceuticals Corporation Pharmaceutical formulations for 1,4-dihyrdropyridine compounds having improved solubility
US11512052B2 (en) * 2017-11-21 2022-11-29 Icahn School Of Medicine At Mount Sinai Dihydropyridines for the treatment of cognitive impairment or traumatic brain injury

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1963188A1 (de) * 1969-12-17 1971-06-24 Bayer Ag Neue Cyanphenyl-1,4-dihydropyridinderivate
DE2117572C3 (de) * 1971-04-10 1980-03-20 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin ^-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
US3932646A (en) * 1971-04-10 1976-01-13 Farbenfabriken Bayer Ag Pharmaceutical compositions containing unsymmetrical esters of 1,4-dihydropyridine 3,5-dicarboxylate
DE2508181A1 (de) * 1975-02-26 1976-09-09 Bayer Ag 1,4-dihydropyridincarbonsaeurearal- kylester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2815578C2 (de) * 1978-04-11 1986-01-16 Bayer Ag, 5090 Leverkusen Neue pharmazeutische Verwendung von Nimodipin
DE2935451A1 (de) * 1979-09-01 1981-03-19 Bayer Ag, 5090 Leverkusen Optisch aktive 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arneimittel
DE3208628A1 (de) * 1982-03-10 1983-09-22 Bayer Ag, 5090 Leverkusen Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3239273A1 (de) * 1982-10-23 1984-04-26 Bayer Ag, 5090 Leverkusen Tetrahydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
US5137889A (en) * 1983-12-02 1992-08-11 Otsuka Pharmaceutical Co., Ltd. Dihydropyridine derivatives and process for preparing the same
DE3718398A1 (de) * 1987-06-02 1988-12-22 Troponwerke Gmbh & Co Kg Neue kombinationspraeparate mit antidepressiver wirkung
US5114946A (en) * 1987-06-12 1992-05-19 American Cyanamid Company Transdermal delivery of pharmaceuticals
DE3806277A1 (de) * 1988-02-27 1989-09-07 Troponwerke Gmbh & Co Kg Verwendung von 1,4-dihydropyridin-derivaten
DE4011695A1 (de) * 1990-04-11 1991-10-17 Bayer Ag Verwendung von n-alkylierten 1,4-dihydropyridindicarbonsaeureestern als arzneimittel, neue verbindungen und verfahren zu ihrer herstellung
FR2671349B1 (fr) * 1991-01-09 1993-04-23 Lafon Labor Nouveaux derives de 1,4-dihydropyridine, leur procede de preparation et composition therapeutique les contenant.
DE4125271A1 (de) * 1991-07-31 1993-02-11 Bayer Ag Neue n-alkylierte 1,4-dihydropyridindicarbonsaeureester

Also Published As

Publication number Publication date
BG62487B1 (bg) 1999-12-30
CA2137525C (en) 2005-07-12
TNSN94127A1 (en) 1995-09-21
PL179973B1 (pl) 2000-11-30
TW412529B (en) 2000-11-21
AU686976B2 (en) 1998-02-12
GR3030436T3 (en) 1999-09-30
CO4290426A1 (es) 1996-04-17
HU9403551D0 (en) 1995-02-28
DZ1831A1 (fr) 2002-02-17
MY111976A (en) 2001-03-31
US5665740A (en) 1997-09-09
YU71794A (sh) 1996-10-18
FI945777A0 (fi) 1994-12-08
RO115800B1 (ro) 2000-06-30
CZ286065B6 (cs) 2000-01-12
BG99249A (en) 1995-09-29
SV1994000072A (es) 1995-08-09
FI945777A (fi) 1995-06-11
EP0657430B1 (de) 1999-06-02
ES2132308T3 (es) 1999-08-16
CN1244525A (zh) 2000-02-16
YU48920B (sh) 2002-11-15
CN1124258C (zh) 2003-10-15
HUT70937A (en) 1995-11-28
JP3751041B2 (ja) 2006-03-01
DK0657430T3 (da) 1999-11-15
FI105681B (fi) 2000-09-29
EP0657430A1 (de) 1995-06-14
CN1109874A (zh) 1995-10-11
KR100332325B1 (ko) 2002-09-04
DE59408350D1 (de) 1999-07-08
NO944787L (no) 1995-06-12
CA2137525A1 (en) 1995-06-11
HRP940967A2 (en) 1997-08-31
SK282399B6 (sk) 2002-01-07
ATE180774T1 (de) 1999-06-15
CZ309394A3 (en) 1995-11-15
CU22713A3 (es) 1996-07-05
IL111922A (en) 1999-05-09
MA23392A1 (fr) 1995-07-01
LV11321B (en) 1996-12-20
KR950017958A (ko) 1995-07-22
NO944787D0 (no) 1994-12-09
JPH07242632A (ja) 1995-09-19
IL111922A0 (en) 1995-03-15
LV11321A (lv) 1996-06-20
NO302362B1 (no) 1998-02-23
HRP940967B1 (en) 1999-12-31
NZ270087A (en) 1996-08-27
SA95160078B1 (ar) 2006-09-25
CN1056606C (zh) 2000-09-20
AU8030694A (en) 1995-06-15
PL306157A1 (en) 1995-06-12
SK151694A3 (en) 1995-07-11
HU215593B (hu) 1999-01-28

Similar Documents

Publication Publication Date Title
RU93058531A (ru) Фторалкоксибензиламинные производные азотсодержащих гетероциклов, фармацевтическая композиция, способ лечения
ATE348829T1 (de) Pharmazeutische zusammensetzungen zur behandlung von störungen des zns oder anderen erkrankungen
NO941884D0 (no) 1,3-substituerte cykloalkener og cykloalkaner som sentralnervesystem-midler
CA2094702A1 (en) Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents
HUP9900927A3 (en) Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
EE03192B1 (et) Isopropüül-(2-metoksüetüül)-4-(2-kloro-3-tsüanofenüül)-1,4-dihüdro-2,6-dimetüülpüri diin-3,5-dikarboksülaat, selle enantiomeerid ja vaheühend, meetodid nimetatud ühendite valmistamiseks ja kasutamine
DE69005557T2 (de) Substituierte 4-Amino-2-butinyl-Harnstoffe und -thioharnstoffe sowie deren Derivate als zentral wirkende muscarinische Mittel.
NO905254L (no) Fremgangsmaate for fremstilling av substituerte cykloheksener.
NO970573D0 (no) Ylidenforbindelser og deres fremstilling
ATE116851T1 (de) 5-aryl-3h-1,2,4-triazol-3-one und ihre verwendung in der behandlung neurodegenerativer beschwerden.
SE9203857D0 (sv) Use of an enantiomeric dihydropyridine
DE68929177T2 (de) Verwendung von Dihydropyridinen zur Vorbeugung und Behandlung cerebraler Durchblutungsstörungen
EP0311053A3 (en) Ameliorant of cerebral circulation and optical isomer of nb-818, processes for its production and its use
NO993126D0 (no) Anvendelse av benzoylalkyl-1,2,3,6-tetrahydropyridiner

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

GB1A Change in the ownership or in the address of the owner
KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20111122